申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
公开号:EP0084408A1
公开(公告)日:1983-07-27
Novel bicyclooctane compounds of the general formula:
wherein
R1 is a hydrogen atom or a C1-C4 alkyl group,
R2 is a hydrogen atom or a C1-C5 alkyl group,
A is a C1-C10 alkylene group,
B is a direct bond, a cycloalkylene, or a group of one of the formulae:
or
(o, m, p-phenylene or phenoxylene),
D is a C1-C5 alkylene or a cycloalkylene group,
X is an ethylene, a vinylene or an ethynylene group,
Y1, Y2 and Y3 are each independently a free or a protected hydroxy group or a pharmaceutically acceptable salt of such a compound wherein R is a hydrogen atom and their pharmaceutically acceptable salts, and their production and use.
The compounds have potent platelet antiaggregation activity and hypotensive activity and are useful in treating and preventing thromboses and in treating hypertension, and the compounds have also potent antisecretory and antiulcerogenic activity and are useful in treating and preventing gastrointestinal ulcer.
通式如下的新型双环辛烷化合物
其中
R1 是氢原子或 C1-C4 烷基、
R2 是氢原子或 C1-C5 烷基
A是C1-C10亚烷基
B 是直接键、环亚烷基或上式中的一个基团:
或
(O、M、对亚苯基或苯二甲苯)、
D 是 C1-C5 亚烷基或环烷基、
X 是乙烯、乙烯基或乙炔基、
Y1、Y2 和 Y3 各自独立地是游离的或受保护的羟基,或这种化合物的药学上可接受的盐,其中 R 是氢原子和它们的药学上可接受的盐,以及它们的生产和使用。
这些化合物具有强效的血小板抗聚集活性和降血压活性,可用于治疗和预防血栓形成以及治疗高血压,这些化合物还具有强效的抗分泌和抗溃疡活性,可用于治疗和预防胃肠道溃疡。